A Conditionally Replicating Adenovirus for Nasopharyngeal Carcinoma Gene Therapy
Open Access
- 30 June 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (6) , 804-817
- https://doi.org/10.1016/j.ymthe.2004.03.016
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The significance of LMP1 expression in nasopharyngeal carcinomaSeminars in Cancer Biology, 2002
- Epstein–Barr virus in the pathogenesis of NPCSeminars in Cancer Biology, 2002
- Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study: Is combined modality treatment really necessary?Radiotherapy and Oncology, 2002
- Replication-selective virotherapy for cancer: Biological principles, risk management and future directionsNature Medicine, 2001
- EBNA-1: a protein pivotal to latent infection by Epstein-Barr virusReviews in Medical Virology, 2000
- Enhancement of Transgene Expression by Cotransfection of oriP Plasmid with EBNA-1 Expression VectorHuman Gene Therapy, 2000
- The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- transE1 Component Requirements for Maximal Replication of E1-Defective Recombinant AdenovirusVirology, 1998
- Crystal Structure of the DNA-Binding Domain of the Epstein–Barr Virus Origin-Binding Protein, EBNA1, Bound to DNACell, 1996
- Etiology of Nasopharyngeal Carcinoma: A ReviewEpidemiologic Reviews, 1993